Abstract
The aim of study is evaluation of trends and changes in management of Benign Prostatic Hyperplasia (BPH)/Lower Urinary Tract Symptoms (LUTS) in recent years. The main change is increasing number of patients on pharmacotherapy and declining surgeries for this.
The alfa1-lytics are very effective with rapid onset of effect and or very popular among urologist and patients. The 5alfa inhibitors are the second main drugs.
There are use very commonly in combination. We evaluated patients treated by pharmacotherapy (n = 4 507) and patients after transurethral resections of prostate (TURP n = 451) and transvesical prostatectomy (TVPE n = 134) for 6 years (2010-2015).
We compared numbers and results these cohorts. We found growth of pharmacotherapy is signifiant, drop in surgical treatment of BPH/LUTS, slight increase the number of TVPE compared for the period 2003-2007.